TABLE 5.
Maternal fatty acids
| Group | Visit | Serum fatty acids | n | Mean | SD | Significance vs placeboa | Significance vs visit 1b |
|---|---|---|---|---|---|---|---|
| EPA-rich fish oil | 1 | EPAc | 42 | 0.29 | 0.18 | NS | — |
| DHAc | 42 | 4.24 | 2.30 | NS | — | ||
| Total omega-3 highly unsaturated fatty acidsd | 42 | 22.10 | 3.72 | NS | — | ||
| 3 | EPAc | 38 | 0.41 | 0.43 | NS | < .05 | |
| DHAc | 38 | 4.38 | 2.42 | NS | NS | ||
| Total omega-3 highly unsaturated fatty acidsd | 38 | 28.20 | 9.86 | NS | NS | ||
| DHA-rich fish oil | 1 | EPAc | 41 | 0.31 | 0.24 | NS | — |
| DHAc | 41 | 4.66 | 2.29 | NS | — | ||
| Total omega-3 highly unsaturated fatty acidsd | 41 | 24.91 | 7.73 | NS | — | ||
| 3 | EPAc | 37 | .38 | .23 | NS | NS | |
| DHAc | 37 | 6.05 | 3.77 | < .05 | < .05 | ||
| Total omega-3 highly unsaturated fatty acidsd | 37 | 36.41 | 9.71 | < .05 | |||
| Placebo | 1 | EPAc | 42 | .34 | .22 | — | — |
| DHAc | 42 | 3.85 | 1.77 | — | — | ||
| Omega-3 highly unsaturated fatty acidsd | 42 | 22.86 | 5.02 | — | — | ||
| 3 | EPAc | 41 | 0.36 | 0.40 | — | NS | |
| DHAc | 41 | 3.70 | 1.62 | — | NS | ||
| Omega-3 highly unsaturated fatty acidsd | 41 | 27.46 | 9.55 | — | NS |
ANOVA, analysis of variance; DHA, docosahexaenoic acid; EPA, eicosapentaenoic acid; NS, not significant; SD, standard deviation.
One-way ANOVA with Tukey’s multiple comparison test;
Student t test and signed rank test;
Expressed as percent of total fatty acids;
Expressed as percent of total highly unsaturated fatty acids.